Capecitabine Improves Survival in Advanced Breast Cancer

Capecitabine Improves Survival in Advanced Breast Cancer

Women with advanced breast cancer had similar survival rates, but less toxicity, with capecitabine compared to classical cyclophosphamide, methotrexate, and fluorouracil (CMF) first-line therapy in a randomized trial.
Enhanced by Zemanta

Populární příspěvky z tohoto blogu

Synoviální sarkom

Implatabilní port

Paraneoplázie